Mental Health Clinics in Salem, IL Accepting Medicare
5 Mental Health Clinics found. Showing 1 - 5
 Lakewood House Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 218 Circle Dr, Salem, IL 62881 Phone: 618-548-3278 |
Moore Than Behavior Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 502 Holly Pl, Salem, IL 62881 Phone: 618-315-4533 |
Community Resource Center, Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 315 Westgate, Salem, IL 62881 Phone: 618-548-2181 Fax: 618-548-1035 |
Behavior Analysis Corporation Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 109 Country Club Est, Salem, IL 62881 Phone: 314-740-5639 |
Salem Counseling Center, P.c. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 200 N Pearl St, Salem, IL 62881 Phone: 618-548-3435 Fax: 618-548-3435 |
News Archive
Researchers evaluate influence of gut microbes on function of immune cells
New research suggests that gut microorganisms do not merely influence immune cell function, but also support the production of immune cells that form the first line of defense against infection.
Combination of resistance training, AT does not benefit cardiac patients
For patients undergoing rehabilitation following cardiac events, aerobic exercise training (AT) is widely recommended. Resistance training (RT) has also been shown to be beneficial because it enhances muscular strength and endurance, functional capacity and independence, and quality of life, while reducing disability.
Mayo Clinic researchers find innovative approaches to reduce early hospital readmissions
A Mayo Clinic review of 47 studies found that 30-day readmissions can be reduced by almost 20 percent when specific efforts are taken to prevent them. Key among these are interventions to help patients deal with the work passed on to them at discharge.
FDA Advisory Committee recommends approval of AstraZeneca's ticagrelor for Acute Coronary Syndromes
AstraZeneca today announced that the US Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee recommended the FDA approve AstraZeneca's investigational drug ticagrelor for the reduction of thrombotic events in patients with Acute Coronary Syndromes.
› Verified 8 days ago